stockrowUnited Therapeutics Corporation (UTHR) vs Zoetis Inc. (ZTS)
- United Therapeutics Corporation UTHR 564.37 −0.24%
- Zoetis Inc. ZTS 79.74 −2.89%
United Therapeutics Corporation and Zoetis Inc. are both Drug Manufacturers Specialty & Generic companies. Zoetis Inc. is the larger, with a market value of $33.9B against $24.3B — 1.4× the size. Zoetis Inc. trades at the lower P/E: 13.4× against 19.7×. United Therapeutics Corporation grew revenue faster over the last twelve months: 1.89% against 1.58%. United Therapeutics Corporation has the higher net margin (38.6% vs 27.7%) and the higher return on invested capital (30.1% vs 19.6%). Across the 22 metrics below, United Therapeutics Corporation leads on 13 and Zoetis Inc. on 9.
Valuation
Profitability
| Metric | UTHR | ZTS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 86.34% | 71.67% | 53.51% |
| Operating margin | 41.45% | 37.13% | 0.00% |
| Net margin | 38.61% | 27.69% | (2.45%) |
| Free cash flow margin | 27.21% | 24.43% | 0.00% |
| Return on equity | 19.13% | 64.91% | (0.80%) |
| Return on assets | 17.11% | 17.84% | (1.67%) |
| Return on invested capital | 30.13% | 19.60% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack